Advanced renal cell carcinoma (RCC) poses a threat to patient survival. Epigenetic remodelling is the pathogenesis of renal cancer. Histone demethylase 4B (KDM4B) is overexpressed in many cancers through various pathways. However, the role of KDM4B in clear cell renal carcinoma has not yet been elucidated. The differential expression of KDM4B was first verified by analysing public databases. The expression of KDM4B in fresh tissues and pathology slides was further analysed by western blotting and immunohistochemical staining. KDM4B overexpression and knockdown cell lines were also established. Cell Counting Kit-8 (CCK-8) assay was used to detect cell growth. Transwell assays were performed to assess cell migration. Xenografts were used to evaluate tumour growth and metastasis . Finally, KDM4B expression levels associated with copy number variation (CNV) and cell cycle stage were evaluated based on single-cell RNA sequencing data. KDM4B was expressed at higher levels in tumour tissues than in the adjacent normal tissues. High levels of KDM4B are associated with worse pathological features and poorer prognosis. KDM4B also promotes cell proliferation and migration , as well as tumour growth and metastasis . Tumour cells with high KDM4B expression exhibited higher CNV levels and a greater proportion of cells in the G1/S transition phase. Our results confirm that KDM4B promotes the progression of clear cell renal carcinoma, is correlated with poor prognosis, and may be related to high levels of CNV and cell cycle progression.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038057 | PMC |
| http://dx.doi.org/10.1080/15592294.2023.2192319 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The integration of conventional omics data such as genomics and transcriptomics data into artificial intelligence models has advanced significantly in recent years; however, their low applicability in clinical contexts, due to the high complexity of models, has been limited in their direct use inpatients. We integrated classic omics, including DNA mutation and RNA gene expression, added a novel focus on promising omics methods based on A>I(G) RNA editing, and developed a drug response prediction model. We analyzed 104 patients from the Breast Cancer Genome-Guided Therapy Study (NCT02022202).
View Article and Find Full Text PDFLarge-scale exome sequencing identified 18 novel genes for neuroticism in 394,005 UK-based individuals.
Nat Hum Behav
November 2024
Department of Neurology and National Center for Neurological Disorders, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China.
Article Synopsis
- Existing research on neuroticism primarily focused on common genetic variants, but this study examines rare coding variants through a large exome analysis in white British individuals from UK Biobank.
- The analysis identified 14 genes associated with neuroticism, including 12 novel genes and 2 that have previously shown links with common variants, with a heritability estimate of 7.3% for rare variants.
- The study also found 78 significant associations with common variants, implicating 6 new genes, and demonstrated widespread effects on neuropsychiatric disorders and cognitive abilities, highlighting potential targets for future research.
Ribosomal S6 kinase (RSK) plays a critical role in DNA damage response via the phosphorylation of histone lysine demethylase KDM4B.
Breast Cancer Res
October 2024
Department of Translational Oncology, St. Marianna University Graduate School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.
Background: Epigenetic dysregulation affecting oncogenic transcription and DNA damage response is a hallmark of cancer. The histone demethylase KDM4B, a factor regulating these processes, plays important roles in estrogen receptor-mediated transcription and DNA repair in breast cancer. However, how oncogenic phospho-signal transduction affects epigenetic regulation is not fully understood.
View Article and Find Full Text PDFH3K9me3 demethylation by JMJD2B is regulated by pirfenidone resulting in improved NASH.
Sci Rep
October 2024
Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, Health Sciences University Center, University of Guadalajara, 44340, Guadalajara, Jalisco, Mexico.
NASH is characterized by hepatic lipid accumulation and inflammation; and JMJD2B-a histone demethylase-upregulation has been linked to its progression. Pirfenidone (PFD) is an antifibrotic agent with anti-inflammatory and antioxidant effects recognized to decrease NASH symptoms. Herein, our aim was to investigate PFD-induced epigenetics mechanisms involving JMJD2B and histone modifications in experimental NASH.
View Article and Find Full Text PDFYam Carbon Dots Promote Bone Defect Repair by Modulating Histone Demethylase 4B.
Int J Nanomedicine
October 2024
Department of Endodontics and Periodontics, College of Stomatology, Dalian Medical University, Dalian, Liaoning, 116044, People's Republic of China.
Article Synopsis
- Chronic apical periodontitis is an inflammatory disease affecting the jawbone, and this study explores the potential of Yam Carbon Dots (YAM-CDs), a new nanomaterial, in healing bone defects.
- The researchers used various methods to analyze YAM-CDs and conducted experiments using stem cells and a mouse model to see how they affect bone healing and differentiation.
- Results showed that YAM-CDs not only encouraged bone cell development under inflammatory conditions but also significantly repaired bone defects in mice while lowering inflammation, suggesting new treatment possibilities for oral and bone-related issues.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!